drugbaron.com
The zero person biotech company | Drug Baron
http://drugbaron.com/the-zero-person-biotech-company
July 31, 2013. The zero person biotech company. Comparing the founding of two virtual drug development companies, Funxional Therapeutics. In 2006 and XO1. Earlier in 2013 proves at least one thing: in just seven years it has become dramatically easier and quicker to create a virtual drug development company. Today it is even possible to take virtual to its logical extreme: a zero person biotech company. But by 2013, the emergence of true Out-Sourced Drug Developers (ODDs) have changed the equation firmly...
obn.org.uk
OBN: Supporting the UK’s Innovative Life Sciences Companies | Consortium Suppliers
http://www.obn.org.uk/purchasing-consortium/consortium-suppliers
How to Join OBN. Your Money Working Smarter. Advice & Advocacy. Laboratory & Office Space. How to Join OBN. Your Money Working Smarter. Advice & Advocacy. Laboratory & Office Space. Information on the offers available from our suppliers and contact details are shown below. For more detailed information about the deals available to your company please mail, Lee Pratley. Or call him on 01235 420 877. Laboratory Consumables, Equipment, Chemicals and Services. 8211; Average 45% off list price. For many indus...
drugdiscoverychemistry.com
Fragment-Based Drug Discovery Conference
http://www.drugdiscoverychemistry.com/Fragment-Based-Drug-Discovery
From Hits to Leads and Lessons Learned. April 25-26, 2017 Sheraton San Diego Hotel and Marina. Scientific Advisor: Daniel A.Erlanson, Ph.D., Co-Founder,CarmotTherapeutics, Inc. Day 1 Day 2. Tuesday, April 25. FRAGMENTS TO LEADS AND CANDIDATES. Daniel A. Erlanson, Ph.D., Co-Founder, Carmot Therapeutics, Inc. Late-Breaking Presentation: Expanding the Ligandable Proteome: Ligand and Target Discovery by Fragment-Based Screening in Human Cells. Small molecule inhibitors of interleukin-1 receptor-associated ki...
drugdiscoverychemistry.com
Macrocyclics and Constrained Peptides Conference
http://www.drugdiscoverychemistry.com/macrocyclics
Macrocyclics and Constrained Peptides. Bigger, Better and Still Oral Small Molecules. April 25-26, 2017 Sheraton San Diego Hotel and Marina. Day 1 Day 2. Tuesday, April 25. DESIGNING FOR CELL-PERMEABILITY AND OTHER Ro5 FEATURES. Jan Kihlberg, Ph.D., Professor, Organic Chemistry, Uppsala University. FEATURED PRESENTATION: Macrocyclic Secondary Structure: Permeability and Chemical Biology. Spiros Liras, Ph.D., Vice President, Head, Cardiovascular Metabolism, RDRU and Discovery Network, Pfizer, Inc. Permeab...
bpa14.biopartner.co.uk
All attending UK organisations
http://bpa14.biopartner.co.uk/page/all
All attending UK organisations. As part of the official UK group. UK companies associated with the delegation*:. Alacrita, BioMoti, Brainwave Discovery, Clinical Network Services. Convergence Pharmaceuticals, Critical Pharmaceuticals, Liftstream. PBL, Sygnature Discovery. All attending UK companies:. BioPartnership Programme members are hyperlinked.
SOCIAL ENGAGEMENT